BeyondSpring Inc. Ordinary Shares (BYSI)

About BYSI

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company's lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment o…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

44

Website

beyondspringpharma.com

Fundamentals

1-day range

$0.8652$0.8876

Market cap

$35.77M

P/E (trailing)

—

P/E (forward)

-1.85

EPS (trailing)

$-0.20

Dividend yield

—

Beta

0.12

Avg. volume

29.7K

BeyondSpring Inc. Ordinary Shares Competitors

Chosen by industry and closest market cap.

• BYSI

  BeyondSpring Inc. Ordinary Shares

  $0.665

  ▲ 3.91%
  Market cap $35.77MP/E —
  $0.865$2.44
• NNVC

  NanoViricides Inc. Common Stock

  $1.24

  ▼ 3.12%
  Market cap $35.56MP/E —
  $0.85$2.23
• LTRN

  Lantern Pharma Inc. Common Stock

  $2.08

  ▼ 3.70%
  Market cap $35.47MP/E —
  $1.11$4.7
• IXHL

  Incannex Healthcare Inc. Common Stock

  $3.61

  ▼ 2.17%
  Market cap $37.21MP/E —
  $2.49$20.64
• APLM

  Apollomics Inc. Class A Ordinary Shares

  $26.6

  ▲ 1.14%
  Market cap $37.33MP/E —
  $3.66$42.12
• ENLV

  Enlivex Ltd. Ordinary Shares

  $1.35

  ▼ 8.47%
  Market cap $33.33MP/E 0.02
  $1.35$27.15
• RADX

  Radiopharm Theranostics Limited American Depositary Shares

  $2.41

  ▲ 6.64%
  Market cap $40.11MP/E —
  $0.009$0.04

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• BeyondSpring Q2 EPS $(0.02) Up From $(0.04) YoY
  Benzinga · 8/14/2026
• 12 Health Care Stocks Moving In Friday's Pre-Market Session
  Benzinga · 8/14/2026
• Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
  Benzinga · 8/14/2026
• 12 Health Care Stocks Moving In Thursday's After-Market Session
  Benzinga · 8/13/2026
• 12 Health Care Stocks Moving In Thursday's Intraday Session
  Benzinga · 8/13/2026
• BeyondSpring's Subsidiary SEED Therapeutics Has Received FDA Orphan Drug Designation For ST-01156 For Treatment Of Neuroblastoma
  Benzinga · 8/13/2026

• Majeti Jiangwen · July 1, 2026 · Grant

  100.0K
• Qiu Min · July 1, 2026 · Grant

  100.0K
• Kirkby Matthew · April 1, 2026 · Grant

  23.9K
• Delaney Brendan · April 1, 2026 · Grant

  20.4K
• Majeti Jiangwen · April 1, 2026 · Grant

  21.7K
• Lu Yingjuan June · April 1, 2026 · Grant

  17.8K
• Huang Lan · April 1, 2026 · Grant

  11.5K
• Xu Sihai · April 1, 2026 · Grant

  18.7K
• Patrick Fabbio · April 1, 2026 · Grant

  22.2K
• Huang Lan · March 20, 2026 · Gift

  260.6K